IKS Health: 33% Margins, 5M Records – India's Hidden Healthcare Tech Gem

Inventurus Knowledge Solutions is a healthcare technology company serving US health systems with revenue cycle management, clinical support and value-based care solutions. Managing 5+ million patient records, IKS combines 20%+ growth with ~33% EBITDA margins, offering compelling exposure to India’s healthcare IT export story. IKS uses an asset-light, technology-enabled services model to help US hospitals and physician groups improve billing, collections and clinical workflows. In Q1 FY27 (June 2026), revenue rose 21% YoY to ₹8,936 million, EBITDA reached ₹2,949 million (33% margin) and PAT was ₹1,937 million (21.7% margin). Adjusted PAT, excluding one-time acquisition costs, grew 28% to ₹2,153 million. FY26 revenue increased 20% to ₹31,938 million, while PAT grew 48%, demonstrating strong operating leverage. ROE of 26–40% and Q1 FY27 free cash flow of ₹1,742 million (+27% YoY) highlight strong capital efficiency and cash generation. High margins: 33–35% EBITDA margins indicate strong operational efficiency and pricing power. Growth at scale: 20%+ revenue growth alongside rising profits suggests limited growth-versus-margin trade-off. Strong cash generation: Supports reinvestment, acquisitions, debt reduction and potential shareholder returns. High ROE: 26–40% ROE comfortably exceeds the cost of equity, creating economic value. At ~44x P/E (August 2026), the stock commands a premium valuation and requires sustained high growth. USD/INR movements affect reported performance; Q1 constant-currency growth was 12% versus 21% in rupee terms. Acquisition-related costs, including TruBridge, can temporarily affect margins. IKS Health is a high-quality, high-margin growth company. Sustained 20%+ growth, 33%+ EBITDA margins and 25%+ ROE make it attractive for long-term shareholders. The key risk is valuation compression if growth or margins disappoint.